Kaisa Health Group Holdings Limited (KAISA HEALTH) has issued the proxy form and agenda for its forthcoming Annual General Meeting, scheduled for 29 June 2026 at 11:00 a.m. in Hong Kong’s Office Plus@Sheung Wan. Shareholders holding the company’s HK$0.00125-denominated shares are invited to appoint proxies and vote on a series of ordinary resolutions, all of which will be decided by poll.
Key resolutions: 1. Financial Statements: Shareholders will consider and receive the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and independent auditor’s reports.
2. Board Composition: The meeting proposes the re-election of four retiring directors—executive directors Mr. Ye Haoda and Mr. Kwok Ying Shing, and independent non-executive directors Dr. Lyu Aiping and Ms. Li Zhiying.
3. Directors’ Remuneration: Authority for the board to determine directors’ remuneration for the coming year.
4. Auditor Re-appointment: Proposal to re-appoint ZSZH (HK) Fuson CPA Limited (formerly SFAI (HK) CPA Limited) as independent auditor and mandate the board to set its remuneration.
5. Share Mandates: • General mandate for directors to allot, issue and deal with additional shares. • General mandate for the company to repurchase its own shares. • Extension of the issuance mandate by the number of shares the company repurchases.
6. Share Scheme Adoption: Introduction of a new share scheme, details of which are outlined in the meeting notice.
Administrative details: • Shareholders may appoint the Chairman or another proxy to vote on their behalf; completed proxy forms must be lodged with Computershare Hong Kong Investor Services Limited at least 48 hours before the meeting. • Joint holders will have voting rights exercised by the senior holder present. • Attendance in person revokes any previously submitted proxy.
These agenda items collectively aim to refresh corporate governance, maintain audit oversight, provide flexibility for capital management, and align employee incentives with shareholder interests ahead of the 2026 financial year.